Table 2.
HPV genotypes detected in all women studied including with normal cytology (controls), with cervical abnormalities (cases) and also with Chlamydia trachomatis (Ct) without considered HPV multiple infections
| HPV genotypes | NILM (n = 370) | Cervical abnormalities (n = 252) | *P value | Ct (n = 79) | **P value | |||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |||
| HR-HPV | ||||||||
| 16 | 5 | 50.0 | 62 | 46.9 | 0.99 | 13 | 59.1 | 0.99 |
| 51 | – | – | 7 | 5.3 | – | 1 | 4.5 | – |
| 45 | 1 | 10.0 | 8 | 6.1 | 0.84 | 4 | 18.2 | 0.80 |
| 18 | 1 | 10.0 | 7 | 5.3 | 0.81 | – | – | – |
| 82 | – | – | 6 | 4.5 | – | 2 | 9.1 | – |
| 31 | 2 | 20.0 | 10 | 7.7 | 0.60 | 2 | 9.1 | 0.78 |
| 59 | 1 | 10.0 | 7 | 5.3 | 0.81 | – | – | – |
| 35 | – | – | 6 | 4.5 | – | – | – | – |
| 33 | – | – | 8 | 6.1 | – | – | – | – |
| 66 | – | – | 6 | 4.5 | – | – | – | – |
| 52 | – | – | 3 | 2.3 | – | – | – | – |
| 68 | – | – | 2 | 1.5 | – | – | – | – |
| Total | 10 | 100.0 | 132 | 100.0 | 0.99 | 22 | 100.0 | 0.99 |
| LR-HPV | ||||||||
| 72 | 1 | 12.5 | 23 | 36.5 | 0.50 | 6 | 40.0 | 0.50 |
| 42 | – | – | 6 | 9.5 | – | 1 | 6.7 | – |
| 61 | 2 | 25.0 | 1 | 1.5 | 0.55 | 1 | 6.7 | 0.67 |
| 69 | 1 | 12.5 | 3 | 4.8 | 0.77 | 1 | 6.7 | 0.86 |
| 81 | 2 | 25.0 | 4 | 6.3 | 0.57 | – | – | – |
| 67 | 2 | 25.0 | 1 | 1.5 | 0.55 | 1 | 6.7 | 0.66 |
| 53 | – | – | 2 | 3.2 | – | 2 | 13.3 | – |
| 40 | – | – | 1 | 1.5 | – | 1 | 6.7 | – |
| 11 | – | – | 3 | 4.8 | – | 2 | 13.3 | – |
| Others1 | 20 | |||||||
| Total | 8 | 100.0 | 63 | 100.0 | 0.99 | 15 | 100.0 | 0.99 |
P value < 0.05 is considered significant.
Cytology findings: controls (normal –NILM) cases: atypical glandular cells, atypical squamous cells of undetermined significance or -cannot exclude high-grade squamous intraepithelial cervical lesion, low-grade or high-grade squamous intraepithelial cervical lesion, and squamous cervical carcinoma. HPV = HPV positive; HR-HPV = high-risk HPV; LR-HPV = low-risk HPV; Ct = Chlamydia trachomatis positive; Others1 = 6, 13, 39, 54, 58, 62 and 70.
P value compared normal cytology versus cervical abnormalities.
P value compared Chlamydia detection versus HPV genotypes.